AVE 33.3% 0.2¢ avecho biotechnology limited

iah add, page-24

  1. 1,912 Posts.
    lightbulb Created with Sketch. 214
    "Drug discovery is the most difficult to pick".

    That's why we are here in POH.

    Any thoughts why we have such a BS SP. I would like a little more communication about the revenue/revenue comments in the presentation last week

    "we expect revenue to significantly increase during 2014"

    Everyone remember the announcement 2 years back "Elixia/Bodyshaper hits $1 million in sales" we need something like that about animal health and Novartis.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.